SYSTEMATIC REVIEW REGISTER

N/A

Studies that include participants of both the genders over the age of 18 years with cervical radiculopathy caused by cervical disc pathology will be included. Studies which include patients with acute, sub-acute, or chronic discogenic cervical radiculopathy will be considered.

In this scoping review, we will consider studies that include deceased organ donors, both DCD and NDD, in any country. Terms to describe deceased organ donors vary worldwide, so we are considering the following terms valid: organ donation, tissue and organ procurement, organ donation process, donation after circulatory death, organ donation after circulatory determination of death, non-heart beating donation, organ donation after neurological determination of death, brain death donor, donation after neurologic death, organ retrieval, organ procurement, dead donor rule, tissue and organ harvesting, organ donor, tissue donor, donor, body donation, donation/procurement of organ/tissues, cardiocirculatory death, cardiac death, DCD or NDD. For the purposes of this review “any country” refers to countries that are considered low, middle, and high resource/income.

Australian workers.

Male partners whose wives used maternity waiting homes in their last births.

This review will consider any studies that include sports men and women of any age group, participating in both recreational and elite sports. Participants with or without ankle injuries will be included. Studies reporting on athletes with other musculoskeletal injuries other than ankle injuries or post-surgical cases will be excluded from this review. 

Registered health care providers regardless of age, gender or years of experience.

Patients with mild-moderate symptoms that are at high risk of progression to severe disease.

POPULATION:
Patients diagnosed with Orofacial pain AND
Inclusion criteria:
i. Age > 18 years
ii. A diagnosis of Orofacial pain.

Exclusion criteria:
Conditions that can influence pain sensitivity, such as systemic inflammatory connective tissue diseases (e.g., rheumatoid arthritis); whiplash-associated disorders; chronic widespread muscle pain conditions (e.g., fibromyalgia); neuropathic pain or neurological disorders (e.g., oromandibular dystonia); pain of dental origin; pregnancy or lactation; high blood pressure; and ongoing dental treatment. Another exclusion criterion is medication that could interfere with the blood analysis or pain sensitivity (e.g., anticoagulant treatment and analgesic consumption within 1 week before the experiment, for example, of paracetamol, NSAIDs (Non-steroidal anti-inflammatory drugs), salicylate drugs, or opioids) or that could influence pain perception (e.g., anti-depressants or antiepileptic drugs). Exclusion criteria will be assessed in each subject by taking a medical history.
 

Adults and children